Cyprus reports surge in antibiotic-resistant infections amid national strategy launch
On European Antibiotic Awareness Day, November 18, 2026, new data from the European Centre for Disease Prevention and Control (ECDC) revealed a concerning rise in antimicrobial resistance in Cyprus. Between 2019 and 2025, blood infections caused by carbapenem-resistant Klebsiella pneumoniae spiked by 715.7%, while third-generation cephalosporin-resistant E. coli cases increased by 275.8% and MRSA infections by 76.2%. Despite a 25% reduction in overall antibiotic consumption since 2019, Cyprus remains the sixth-highest consumer in the EU, with 22.2 daily doses per 1,000 inhabitants.
Health experts, including Dr. Zoe Pana of the University of Nicosia, warn that hospitals are struggling to treat multidrug-resistant infections due to a lack of effective medication. The Ministry of Health emphasized that antibiotics are ineffective against viral illnesses, such as the common cold, and urged parents to use them only when prescribed. To address this public health threat, Cyprus is launching a National Strategy to combat antimicrobial resistance for the 2026–2030 period, which focuses on surveillance, professional training, and public awareness campaigns to ensure the rational use of these medications.